Clément Bresteau
Hôpital Beaujon(FR)Assistance Publique – Hôpitaux de Paris(FR)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Autoimmune and Inflammatory Disorders, Microscopic Colitis, Tuberculosis Research and Epidemiology, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort(2021)52 cited
- → Chronic pouchitis and Crohn's disease of the pouch after ileal pouch-anal anastomosis: Incidence and risk factors(2021)17 cited
- → Serious immune‐related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series(2023)16 cited
- → Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse(2018)13 cited
- → Do we still need a diverticuloscope for the flexible endoscopic septotomy of Zenker's diverticulum?(2019)11 cited
- → Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID(2023)10 cited
- → Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: A prospective cohort study(2025)2 cited
- → French recommendations for the management of Crohn’s disease – Short version(2024)1 cited
- → P0641 Efficacy of Vedolizumab and Ustekinumab Following Cyclosporine Induction in Acute Severe Ulcerative Colitis: A Retrospective Cohort Study(2025)
- → Immune check-point inhibitors related enterocolitis(2023)